In five independent studies, the activity of the tumor suppressor miR-34a was replenished using: (i) hTERT promoter-driven VISA liposomal NPs [59]; (ii) polymeric hybrid nanomicelles simultaneously delivering doxorubicin (Dox) [28]; (iii) dextrin-PEI-CM nanoplex (DPC) also delivering a cyclam monomer (a CXCR antagonist) [65]; (iv) silica dioxide NPs (SiO2NPs) [99]; and a (v) lipid core–shell nanocarrier coated with cationic albumin co-delivering docetaxel [135]. Here, ALB is linked to neoplasm.